Federico Mingozzi
Company: Spark Therapeutics
Job title: Chief Scientific Officer
Seminars:
PANEL Q&A: An Overview & Assessment of Current & Future Strategies to Circumvent or Lessen the Innate & Early Adaptive Immune Response to Gene Therapy 12:30 pm
day: Re-Dosing Discussion Day
An Introduction to Gene Therapy Delivery & Immune Response & It’s Implications for Re-Dosing 10:00 am
day: Re-Dosing Discussion Day